Zobrazeno 1 - 10 of 42 pro vyhledávání: '"Lukas Binder"'
1
Akademický článek
Hematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease: Should It Be Considered?
Autor: Simon Reider, Lukas Binder, Stefan Fürst, Stefan Hatzl, Andreas Blesl
Publikováno v: Cells, Vol 11, Iss 21, p 3463 (2022)
Hematopoietic stem cell transplantation (HSCT) is widely used in benign and malignant hematological diseases. During the last decade, HSCT, mainly autologous, also gained increasing attention in the treatment of refractory autoimmune diseases. Crohn
Externí odkaz: https://doaj.org/article/6c86c3b0e290423cb084e09b8a781b6d
Zobrazit plný text záznamu
2
Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective study
Autor: Andreas Blesl, Wolfgang Petritsch, Lukas Binder, Stefan Fürst, Heimo Wenzl, Franziska Baumann-Durchschein, Patrizia Kump, Christoph Högenauer
Publikováno v: Scandinavian Journal of Gastroenterology. 57:1327-1330
Immunological treatment failure of anti-TNF therapy negatively influences treatment persistence of a second anti-TNF in IBD patients. So far it is unknown if this effect is also observed for other monoclonal antibodies. We assessed the influence of i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb7362151b949e3bff0b61726c79f976
https://doi.org/10.1080/00365521.2022.2088248
Zobrazit plný text záznamu
5
Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study
Autor: Andrea Borenich, Christoph Högenauer, Lukas Binder, Patrizia Kump, Andreas Blesl, Franziska Baumann-Durchschein, Wolfgang Petritsch, Sigrid Mestel, Gudrun Pregartner, Andrea Berghold, Heimo H. Wenzl
Publikováno v: Alimentary Pharmacology & Therapeutics
Summary Background Anti‐TNF antibodies were the first biologic treatment option for patients with inflammatory bowel diseases. Aims To assess length of treatment persistence of first anti‐TNF therapy and influencing factors used in the standard c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8536c145abbc7e00559fb78c6b128d6
https://doi.org/10.1111/apt.16478
Zobrazit plný text záznamu
6
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease
Autor: L. Terracciano, Lukas Binder, Marion Jager, Rudolf E. Stauber, Valérie Paradis, Helmut Denk, Sönke Detlefsen, Christophe Moreno, Maria Guido, Andrea Berghold, Annette S. H. Gouw, Rosa Miquel, Florian Rainer, Susan E. Davies, Maja Thiele, Philipp Douschan, Dina Tiniakos, Carolin Lackner, Adelina Horhat, Stephan Sygulla, Andreea Bumbu, Helena Cortez-Pinto, Ioana Rusu, Pierre-Emmanuel Rautou, Hans Peter Dienes, Viviane Gnemmi, Horia Stefanescu, Peter Schirmacher, Aleksander Krag, Gudrun Pregartner
Publikováno v: Lackner, C, Stauber, R E, Davies, S, Denk, H, Dienes, H P, Gnemmi, V, Guido, M, Miquel, R, Paradis, V, Schirmacher, P, Terracciano, L, Berghold, A, Pregartner, G, Binder, L, Douschan, P, Rainer, F, Sygulla, S, Jager, M, Rautou, P-E, Bumbu, A, Horhat, A, Rusu, I, Stefanescu, H, Detlefsen, S, Krag, A, Thiele, M, Cortez-Pinto, H, Moreno, C, Gouw, A S H & Tiniakos, D G 2021, ' Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease ', Journal of Hepatology, vol. 75, no. 4, pp. 810-819 . https://doi.org/10.1016/j.jhep.2021.05.029
Journal of hepatology
Journal of Hepatology, 75(4), 810-819. ELSEVIER SCIENCE BV
Background & Aims: The SALVE Histopathology Group (SHG) developed and validated a grading and staging system for the clinical and full histological spectrum of alcohol-related liver disease (ALD) and evaluated its prognostic utility in a multinationa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3adcde886ed51a49612c2df682bea720
https://pubmed.ncbi.nlm.nih.gov/34537270
Zobrazit plný text záznamu
8
P424 Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years
Autor: Andrea Borenich, Heimo H. Wenzl, Andreas Blesl, Wolfgang Petritsch, Christoph Högenauer, F Baumann-Durchschein, S Mestel, Lukas Binder, Gudrun Pregartner, Patrizia Kump, Andrea Berghold
Publikováno v: Journal of Crohn's and Colitis. 15:S427-S428
Background Anti-TNF therapy is still the most frequently used first-line biologic treatment in inflammatory bowel disease (IBD). This study aimed to determine length of treatment persistence and to describe reasons for discontinuation of first-line a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef481729371ed0b67c89c8237539fbb7
https://doi.org/10.1093/ecco-jcc/jjab076.548
Zobrazit plný text záznamu
9
Gastrointestinal effects of an attempt to avoid contracting COVID‐19 by ‘disinfection’
Autor: Cord Langner, Christoph Högenauer, Lukas Binder
Publikováno v: Histopathology
Summary In April 2020 during the COVID‐19 pandemic, a 41‐year‐old female presented to the emergency department with recurrent vomiting and abdominal pain that had been ongoing on for two days and additional hematemesis for several hours. The pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64479dc58160d9cae1c1f8c4c63a8d6
https://doi.org/10.1111/his.14137
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje